Tag: Fludarabine

Medac resubmits treosulfan NDA to FDA, says Medexus Pharmaceuticals

pallavi123- July 30, 2022

Medexus Pharmaceuticals said that its strategic partner medac has resubmitted the new drug application (NDA) for treosulfan with the US Food and Drug Administration (FDA). ... Read More

Race Oncology doses first patient in phase 1b/2 AML trial of FluCloZan

pallavi123- August 9, 2021

Race Oncology has dosed the first patient in the phase 1b/2 trial of its Zantrene (bisantrene dihydrochloride) in combination with Fludarabine and Clofarabine (FluCloZan) in ... Read More